MinorVitamins. Haemopoietic stimulants×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Sertraline is metabolised in the liver by several pathways, including CYP3A4, CYP2C19 and CYP2B6, and has a half-life of about 26 hours (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). Folic acid is absorbed in the duodenum and jejunum and converted in the liver to 5-methyltetrahydrofolate (Acfol SmPC, AEMPS, section 5.2). The folic acid SmPC lists the substances that impair folate absorption or metabolism, and antidepressants are not among them. The sertraline SmPC does not name folic acid (AEMPS, section 4.5).
Symptoms
The documents describe no symptoms caused by this combination. Sertraline can lower blood sodium and increase the risk of bleeding, especially with drugs that affect platelet function (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Prolonged high doses of folic acid can lower blood vitamin B12 levels (Acfol SmPC, AEMPS, section 4.4).
Management
According to the documents, the combination is acceptable and no dose change of sertraline or folic acid is needed. Neither document names the pair, and sertraline is not among the substances that impair folate use (Besitran and Acfol SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). With long-term high doses of folic acid, bear in mind that it can lower blood vitamin B12 levels (Acfol SmPC, AEMPS, section 4.4). In symptomatic hyponatraemia on sertraline, stopping sertraline is considered (Besitran SmPC, AEMPS, section 4.4).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Sertralina (Besitran 50 mg) (nº registro 59717), secciones 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 59717, revisión 08/2025, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Ácido fólico, Acfol 5 mg comprimidos (nº registro 11265), sección 4.5 (2022)– AEMPS, CIMA, nº registro 11265 (Acfol 5 mg comprimidos, Italfarmaco), revisión 11/2022, secciones 4.1, 4.3, 4.4, 4.5 y 5.2